4 results match your criteria: "Centre of Relevance and Excellence in New Drug Delivery System[Affiliation]"

Facile Synthesis of Chitosan Capped Mesoporous Silica Nanoparticles: A pH Responsive Smart Delivery Platform for Raloxifene Hydrochloride.

AAPS PharmSciTech

April 2018

Faculty of Pharmacy, Centre of Relevance and Excellence in New Drug Delivery System, Government of India, The Maharaja Sayajirao University of Baroda, Kalabhavan Campus, Vadodara, 390002, India.

An encapsulation of model drug raloxifene hydrochloride (RAL) inside the chitosan decorated pH responsive mesoporous system has a greater potential for accumulating in the tumor cells. The present study involves synthesis of surface modified mesoporous silica nanoparticles (MSN) with the aim of achieving pH sensitive drug delivery system. A silanol skeleton of MSN has been productively modified to amine intermediate which served as a firm platform to adapt chitosan grafted assembly and systematically evaluated.

View Article and Find Full Text PDF

The aim of this study was to develop methotrexate loaded mesoporous MCM-41 nanoparticles for improved dissolution of methotrexate. The mesoporous MCM-41 nanoparticles act as carrier for drug and increase the solubility of the drug. In order to achieve this objective small pore size MCM-41 nanoparticles have been synthesized followed by drug loading process.

View Article and Find Full Text PDF

Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.

Curr Drug Deliv

July 2007

TIFAC-Centre of Relevance and Excellence in New Drug Delivery System, Pharmacy Department, The Maharaja Sayajirao University of Baroda, Fatehgunj, Vadodara 390002, Gujarat, India.

The present study was aimed at developing a sustained release formulation of Nimodipine (NIM) nanoparticles using the biodegradable polymers, poly (lactide-co-glycolide) (PLGA 50:50 and 85:15) as carrier. NIM is a widely used calcium channel blocker which has to be administered as an intravenous infusion for a prolonged period of 1-2 weeks in the treatment of cerebral vasospasm. A sustained release biodegradable formulation would serve to replace this conventional therapy of continuous intravenous administration.

View Article and Find Full Text PDF

Albumin microspheres as carriers for the antiarthritic drug celecoxib.

AAPS PharmSciTech

September 2005

Drug Delivery Laboratory, Centre of Relevance and Excellence in New Drug Delivery system Pharmacy Department, MS University of Baroda, Fatehgunj, Vadodara-390 002, India.

The present study investigates the preparation of celecoxib-loaded albumin microspheres and the biodistribution of technetium-99m ((99m)Tc)-labeled celecoxib as well as its microspheres after intravenous administration. Microspheres were prepared using a natural polymer BSA using emulsification chemical cross-linking method. The prepared microspheres were characterized for entrapment efficiency, particle size, and in vitro drug release.

View Article and Find Full Text PDF